Ericson M, Freeman K, Larson C, Bouchard J, John K, Lunzer M
ACS Pharmacol Transl Sci. 2024; 7(4):1114-1125.
PMID: 38633589
PMC: 11020072.
DOI: 10.1021/acsptsci.4c00011.
Ericson M, Freeman K, Lavoi T, Donow H, Santos R, Giulianotti M
Int J Mol Sci. 2023; 24(12).
PMID: 37373293
PMC: 10299128.
DOI: 10.3390/ijms241210145.
Zahn I, Garreis F, Schicht M, Rotzer V, Waschke J, Liu Y
Int J Mol Sci. 2022; 23(23).
PMID: 36499274
PMC: 9737810.
DOI: 10.3390/ijms232314947.
Ericson M, Larson C, Freeman K, Nicke L, Geyer A, Haskell-Luevano C
ACS Omega. 2022; 7(31):27656-27663.
PMID: 35967074
PMC: 9366794.
DOI: 10.1021/acsomega.2c03307.
Wang X, Xue S, Lei X, Song W, Li L, Li X
Front Endocrinol (Lausanne). 2022; 13:820896.
PMID: 35250878
PMC: 8891371.
DOI: 10.3389/fendo.2022.820896.
Pharmacological modulation of the cAMP signaling of two isoforms of melanocortin-3 receptor by melanocortin receptor accessory proteins in the tetrapod Xenopus laevis.
Xu Y, Li L, Zheng J, Wang M, Jiang B, Zhai Y
Endocr Connect. 2021; 10(11):1477-1488.
PMID: 34678757
PMC: 8630767.
DOI: 10.1530/EC-21-0179.
Functional Mixture-Based Positional Scan Identifies a Library of Antagonist Tetrapeptide Sequences (LAtTeS) with Nanomolar Potency for the Melanocortin-4 Receptor and Equipotent with the Endogenous AGRP(86-132) Antagonist.
Ericson M, Doering S, Larson C, Freeman K, Lavoi T, Donow H
J Med Chem. 2021; 64(19):14860-14875.
PMID: 34592820
PMC: 8533642.
DOI: 10.1021/acs.jmedchem.1c01417.
The melanocortin pathway and energy homeostasis: From discovery to obesity therapy.
Yeo G, Herrera Moro Chao D, Siegert A, Koerperich Z, Ericson M, Simonds S
Mol Metab. 2021; 48:101206.
PMID: 33684608
PMC: 8050006.
DOI: 10.1016/j.molmet.2021.101206.
Discovery of Molecular Interactions of the Human Melanocortin-4 Receptor (hMC4R) Asp189 (D189) Amino Acid with the Endogenous G-Protein-Coupled Receptor (GPCR) Antagonist Agouti-Related Protein (AGRP) Provides Insights to AGRP's Inverse Agonist....
Ericson M, Haslach E, Schnell S, Freeman K, Xiang Z, Portillo F
ACS Chem Neurosci. 2021; 12(3):542-556.
PMID: 33470098
PMC: 7951137.
DOI: 10.1021/acschemneuro.0c00755.
Peptoid NPhe in AGRP-Based c[Pro-Arg-Phe-Phe-Xxx-Ala-Phe-DPro] Scaffolds Maintain Mouse MC4R Antagonist Potency.
Ericson M, Freeman K, Haskell-Luevano C
ACS Med Chem Lett. 2020; 11(10):1942-1948.
PMID: 33062177
PMC: 7549258.
DOI: 10.1021/acsmedchemlett.9b00641.
Comparative Intracerebroventricular and Intrathecal Administration of a Nanomolar Macrocyclic Melanocortin Receptor Agonist MDE6-5-2c (c[Pro-His-DPhe-Arg-Trp-Dap-Ala-DPro]) Decreases Food Intake in Mice.
Adank D, Lunzer M, Ericson M, Koeperich Z, Wilber S, Fleming K
ACS Chem Neurosci. 2020; 11(19):3051-3063.
PMID: 32822157
PMC: 7605118.
DOI: 10.1021/acschemneuro.0c00409.
Anti-inflammatory effects of α-MSH through p-CREB expression in sarcoidosis like granuloma model.
Zhang C, Chery S, Lazerson A, Altman N, Jackson R, Holt G
Sci Rep. 2020; 10(1):7277.
PMID: 32350353
PMC: 7190699.
DOI: 10.1038/s41598-020-64305-9.
Melanocortin 5 receptor signaling pathway in health and disease.
Xu Y, Guan X, Zhou R, Gong R
Cell Mol Life Sci. 2020; 77(19):3831-3840.
PMID: 32248247
PMC: 7511443.
DOI: 10.1007/s00018-020-03511-0.
Single Nucleotide Polymorphisms in the Melanocortin His-Phe-Arg-Trp Sequences Decrease Tetrapeptide Potency and Efficacy.
Winget M, Ericson M, Freeman K, Haskell-Luevano C
ACS Med Chem Lett. 2020; 11(3):272-277.
PMID: 32184956
PMC: 7073882.
DOI: 10.1021/acsmedchemlett.9b00198.
Incorporation of Agouti-Related Protein (AgRP) Human Single Nucleotide Polymorphisms (SNPs) in the AgRP-Derived Macrocyclic Scaffold c[Pro-Arg-Phe-Phe-Asn-Ala-Phe-dPro] Decreases Melanocortin-4 Receptor Antagonist Potency and Results in the....
Koerperich Z, Ericson M, Freeman K, Speth R, Pogozheva I, Mosberg H
J Med Chem. 2019; 63(5):2194-2208.
PMID: 31845801
PMC: 7250496.
DOI: 10.1021/acs.jmedchem.9b00860.
Discovery of a Highly Selective MC1R Agonists Pentapeptide to Be Used as a Skin Pigmentation Enhancer and with Potential Anti-Aging Properties.
Jackson E, Heidl M, Imfeld D, Meeus L, Schuetz R, Campiche R
Int J Mol Sci. 2019; 20(24).
PMID: 31817532
PMC: 6940745.
DOI: 10.3390/ijms20246143.
Structure⁻Activity Relationships of the Tetrapeptide Ac-His-Arg-(I)DPhe-Tic-NH at the Mouse Melanocortin Receptors: Modification at the (I)DPhe Position Leads to mMC3R Versus mMC4R Selective Ligands.
Schlasner K, Ericson M, Doering S, Freeman K, Weinrich M, Haskell-Luevano C
Molecules. 2019; 24(8).
PMID: 31013889
PMC: 6515519.
DOI: 10.3390/molecules24081463.
Discovery of Polypharmacological Melanocortin-3 and -4 Receptor Probes and Identification of a 100-Fold Selective nM MC3R Agonist versus a μM MC4R Partial Agonist.
Fleming K, Freeman K, Powers M, Santos R, Debevec G, Giulianotti M
J Med Chem. 2019; 62(5):2738-2749.
PMID: 30741545
PMC: 6463894.
DOI: 10.1021/acs.jmedchem.9b00053.
Synergistic Multiresidue Substitutions of a Macrocyclic c[Pro-Arg-Phe-Phe-Asn-Ala-Phe-dPro] Agouti-Related Protein (AGRP) Scaffold Yield Potent and >600-Fold MC4R versus MC3R Selective Melanocortin Receptor Antagonists.
Fleming K, Freeman K, Ericson M, Haskell-Luevano C
J Med Chem. 2018; 61(17):7729-7740.
PMID: 30035543
PMC: 6174881.
DOI: 10.1021/acs.jmedchem.8b00684.
Arg-Phe-Phe d-Amino Acid Stereochemistry Scan in the Macrocyclic Agouti-Related Protein Antagonist Scaffold c[Pro-Arg-Phe-Phe-Xxx-Ala-Phe-DPro] Results in Unanticipated Melanocortin-1 Receptor Agonist Profiles.
Ericson M, Koerperich Z, Freeman K, Fleming K, Haskell-Luevano C
ACS Chem Neurosci. 2018; 9(12):3015-3023.
PMID: 29924583
PMC: 6339850.
DOI: 10.1021/acschemneuro.8b00218.
